Showing 141 - 160 results of 48,000 for search '(( 16 we decrease ) OR ((( 50 ((a decrease) OR (teer decrease)) ) OR ( 5 we decrease ))))', query time: 0.80s Refine Results
  1. 141

    S5 Data - by Christoph Anders (4068499)

    Published 2024
    “…<div><p>Hysteresis refers to a physical phenomenon in which the response or state of a system depends on both the input variable and its history. …”
  2. 142

    Data_Sheet_1_Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.do... by Rebeca Hid Cadena (6956792)

    Published 2019
    “…Our study shows that frequencies of CD80/CD86+ and VISTA+ monocytes were decreased in treated GCA patients only. Moreover, proportions of PD-1+ and VISTA+ Th cells were significantly decreased in GCA patients. …”
  3. 143
  4. 144

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    “…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  5. 145
  6. 146
  7. 147
  8. 148

    Data_Sheet_1_Increased selenium and decreased iron levels in relation to risk of coronary artery disease in patients with diabetes.PDF by Mengyun Tian (14712319)

    Published 2023
    “…No consistent evidence was found for the causal associations between phosphorus and zinc levels, and the risk of CAD in patients with diabetes.</p>Conclusion<p>We provide consistent evidence for the causal effect of increased selenium and decreased iron levels on CAD in patients with diabetes, highlighting the necessity of micronutrient monitoring and application in these patients.…”
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  14. 154

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160